second generation NR2F6 inhibitors (Regen BioPharma)

N/A

Report date: 2025/06/11 10:54:42

NME

Base Information

Drug Namesecond generation NR2F6 inhibitors (Regen BioPharma)

Drug Alias NameRG-NI01RG-NI02

ClassificationSmall molecules

Mechanisms of ActionNR2F6 protein inhibitorsStem cells modulatorsCell differentiation modulators

TargetsNR2F6 protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRegen Biopharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A